SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 16.51 |
| Enterprise Value ($M) | 15.93 |
| Book Value ($M) | 2.26 |
| Book Value / Share | 0.33 |
| Price / Book | 7.29 |
| NCAV ($M) | 0.17 |
| NCAV / Share | 0.02 |
| Price / NCAV | 96.14 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.67 |
| Return on Assets (ROA) | -0.78 |
| Return on Equity (ROE) | -1.05 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.09 |
| Current Ratio | 1.09 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 2.07 |
| Assets | 4.16 |
| Liabilities | 1.90 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -7.01 |
| Net Income | -6.17 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -4.89 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.59 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Stonepine Capital Management, LLC | 9.90 | ||
| 13D | Velan Capital Master Fund LP | 9.99 | ||
| 13G/A | Satterfield Thomas A Jr | 0.00 | ||
| 13D/A | Nijhawan Pardeep | 19.99 | 136.42 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 2,673 | 11,384 | 23.48 | |
| 621 | 10,498 | 5.92 | |
| 808 | 20,104 | 4.02 | |
| 2,704 | 36,326 | 7.44 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| DTIL – Precision BioSciences, Inc. | DWTX – Dogwood Therapeutics, Inc. |
| DYAI – Dyadic International, Inc. | ELDN – Eledon Pharmaceuticals, Inc. |
| ELTX – Elicio Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io